MilliporeSigma has entered into an agreement with HistoCyte Laboratories to be the exclusive multinational distributor of the company’s portfolio of cell line reference products for immunohistochemistry and in situ hybridization.
 
“This collaboration gives customers a cost-effective and practical solution to the problem of tissue heterogeneity,” said Jean-Charles Wirth, Head of Applied Solutions at MilliporeSigma. “These reference materials strengthen MilliporeSigma’s pathology portfolio and provide a robust and standardized means for customers to achieve greater confidence in their analyses.”
 
Under the agreement, MilliporeSigma will employ its sales, marketing and e-commerce expertise to distribute HistoCyte Laboratories’ comprehensive range of pathology slide controls in the US and other select geographies. Outside of these select geographies, HistoCyte Laboratories will continue to reach customers via its own channels.
 
The controls will be available in cell microarray blocks, thereby fitting into laboratory workflows more easily. In block format, they are a more cost-effective standardized material for routine laboratories.

The founders of HistoCyte Laboratories have more than 30 years of experience in the in vitro diagnostics industry. Colin Tristram, who co-founded HistoCyte Laboratories with Ian Milton, said, “We are excited to have our products available and brand promoted within the US and beyond by MilliporeSigma. It allows us to focus on our direct market in the UK and Ireland, as well as concentrate on further product development.”